Miguel Xavier
Fernandes
Investigador en el periodo 2013-2022
Universidade da Madeira
Funchal, PortugalPublicaciones en colaboración con investigadores/as de Universidade da Madeira (25)
2019
-
Effects of hydroxycinnamic acids on the glycolysis pathway
South African Journal of Botany, Vol. 120, pp. 219-229
-
Prediction of terpenoid toxicity based on a quantitative structure–activity relationship model
Foods, Vol. 8, Núm. 12
2015
-
Synthesis and identification of unprecedented selective inhibitors of CK1ε
European Journal of Medicinal Chemistry, Vol. 96, pp. 308-317
2014
-
Dual-stage triterpenoids from an African medicinal plant targeting the malaria parasite
Bioorganic and Medicinal Chemistry, Vol. 22, Núm. 15, pp. 3887-3890
2013
-
Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach
Biochemical Pharmacology, Vol. 85, Núm. 9, pp. 1234-1245
-
Generation of artificial neural networks models in anticancer study
Neural Computing and Applications, Vol. 23, Núm. 3-4, pp. 577-582
-
Molecular docking studies of the interaction between propargylic enol ethers and human DNA topoisomerase IIα
Bioorganic and Medicinal Chemistry Letters, Vol. 23, Núm. 19, pp. 5382-5384
-
Sulfated small molecules targeting EBV in Burkitt lymphoma: From in silico screening to the evidence of in vitro effect on viral episomal DNA
Chemical Biology and Drug Design, Vol. 81, Núm. 5, pp. 631-644
2012
-
Dual inhibitors of P-glycoprotein and tumor cell growth: (Re)discovering thioxanthones
Biochemical Pharmacology, Vol. 83, Núm. 1, pp. 57-68
-
Enantioseparation and chiral recognition mechanism of new chiral derivatives of xanthones on macrocyclic antibiotic stationary phases
Journal of Chromatography A, Vol. 1241, pp. 60-68
-
Interaction of antimicrobial peptides, BP100 and pepR, with model membrane systems as explored by Brownian dynamics simulations on a coarse-grained model.
Biopolymers, Vol. 98, Núm. 4, pp. 294-312
-
Multidrug resistance reversal effects of aminated thioxanthones and interaction with cytochrome P450 3A4
Journal of Pharmacy and Pharmaceutical Sciences, Vol. 15, Núm. 1, pp. 31-45
-
Structure and Ligand-based design of P-glycoprotein inhibitors: A historical perspective
Current Pharmaceutical Design, Vol. 18, Núm. 27, pp. 4197-4214
2011
-
Comparative QSAR analyses of competitive CYP2C9 inhibitors using three-dimensional molecular descriptors
Chemical Biology and Drug Design, Vol. 78, Núm. 1, pp. 112-123
-
New uses for old drugs: Pharmacophore-based screening for the discovery of P-glycoprotein inhibitors
Chemical Biology and Drug Design, Vol. 78, Núm. 1, pp. 57-72
2010
-
Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR
Journal of Biological Chemistry, Vol. 285, Núm. 36, pp. 27536-27544
-
Insights into the in vitro antitumor mechanism of action of a new pyranoxanthone
Chemical Biology and Drug Design, Vol. 76, Núm. 1, pp. 43-58
-
Pharmacophore-Based Screening as a Clue for the Discovery of New P-Glycoprotein Inhibitors
ADVANCES IN BIOINFORMATICS
2009
-
QSAR models for prediction of PPARδ agonistic activity of indanylacetic acid derivatives
QSAR and Combinatorial Science, Vol. 28, Núm. 4, pp. 447-457
-
Simuflex: Algorithms and tools for simulation of the conformation and dynamics of flexible molecules and nanoparticles in dilute solution
Journal of Chemical Theory and Computation, Vol. 5, Núm. 10, pp. 2606-2618